News

Sophie Cunningham is having quite the 2025. Her name has been buzzing for good and bad things for the past few months. The buzz surrounding her started after she was alleged to have had an affair with ...
Analysis: Whether any Bears team should be regarded as one of the top 25 this century is open for debate but what isn't debatable is how worthless ESPN's "great teams" list is.
Sangamo's investigational gene therapy has been tied to an improvement in kidney health deterioration at 52 weeks for patients with Fabry disease.
BACKGROUND: Vascular aging is an important phenotype characterized by structural and geometric remodeling. Some individuals exhibit supernormal vascular aging, associated with improved cardiovascular ...
Last month, a baby got the world’s first personalized gene-editing treatment. What will this mean for millions of others with genetic diseases?
In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, the agency is investigating two Duchenne muscular dystrophy patient ...
FDA evaluating further regulatory actions after deaths Elevidys is the only gene therapy for Duchenne muscular dystrophy Sarepta suggested updating Elevidys' label June 24 (Reuters) - The U.S ...
The U.S. Army Corps of Engineers has awarded a contract option to Kokosing Alberici Traylor LLC for the final $95.3-million phase of the Soo Locks project in Sault Ste. Marie, Mich.—a nearly $3. ...
Google's DeepMind launches AlphaGenome, an artificial intelligence model that predicts gene expression from DNA sequence.
Elon Musk retakes ownership of Gene Wilder's iconic Bel-Air home after foreclosure, preserving its legacy with restrictive covenants.
Bootstrap Bio has hired a chief science officer, opened a lab and sought seed funding to edit human cells that can be passed to future generations ...